Search research articles
Contact Us
Filters
Showing results (521-530 of 566) with videos related to
Page
of 57
Sort By:
Plos Genetics
|
August 26, 2016
Genomewide Association Study of African Children Identifies Association of SCHIP1 and PDE8A with Facial Size and Shape
Joanne B Cole, Mange Manyama, Emmanuel Kimwaga, et al.
The New England Journal of Medicine
|
August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
Mark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Nature Communications
|
September 12, 2018
Microbial metabolite sensor GPR43 controls severity of experimental GVHD
Hideaki Fujiwara, Melissa D Docampo, Mary Riwes, et al.
Science Translational Medicine
|
April 8, 2010
Elafin is a biomarker of graft-versus-host disease of the skin
Sophie Paczesny, Thomas M Braun, John E Levine, et al.
Blood
|
December 24, 2013
Plasma CXCL9 elevations correlate with chronic GVHD diagnosis
Carrie L Kitko, John E Levine, Barry E Storer, et al.
Blood Advances
|
November 9, 2022
Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
Daniela Weber, Markus Weber, Elisabeth Meedt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 14, 2015
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality
Margaret L MacMillan, Marie Robin, Andrew C Harris, et al.
Haematologica
|
December 16, 2017
<i>In vivo</i> IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation
Joseph Pidala, Francisca Beato, Jongphil Kim, et al.
American Journal of Physical Anthropology
|
November 28, 2017
Body size and allometric variation in facial shape in children
Jacinda R Larson, Mange F Manyama, Joanne B Cole, et al.
Blood
|
November 19, 2019
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial
Joseph Pidala, Mehdi Hamadani, Peter Dawson, et al.
Page
of 57
Search research articles
Search
Showing results (521-530 of 566) with videos related to
Sort By:
Page
of 57
Plos Genetics
|
August 26, 2016
Genomewide Association Study of African Children Identifies Association of SCHIP1 and PDE8A with Facial Size and Shape
Joanne B Cole, Mange Manyama, Emmanuel Kimwaga, et al.
The New England Journal of Medicine
|
August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
Mark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Nature Communications
|
September 12, 2018
Microbial metabolite sensor GPR43 controls severity of experimental GVHD
Hideaki Fujiwara, Melissa D Docampo, Mary Riwes, et al.
Science Translational Medicine
|
April 8, 2010
Elafin is a biomarker of graft-versus-host disease of the skin
Sophie Paczesny, Thomas M Braun, John E Levine, et al.
Blood
|
December 24, 2013
Plasma CXCL9 elevations correlate with chronic GVHD diagnosis
Carrie L Kitko, John E Levine, Barry E Storer, et al.
Blood Advances
|
November 9, 2022
Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
Daniela Weber, Markus Weber, Elisabeth Meedt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 14, 2015
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality
Margaret L MacMillan, Marie Robin, Andrew C Harris, et al.
Haematologica
|
December 16, 2017
<i>In vivo</i> IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation
Joseph Pidala, Francisca Beato, Jongphil Kim, et al.
American Journal of Physical Anthropology
|
November 28, 2017
Body size and allometric variation in facial shape in children
Jacinda R Larson, Mange F Manyama, Joanne B Cole, et al.
Blood
|
November 19, 2019
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial
Joseph Pidala, Mehdi Hamadani, Peter Dawson, et al.
Page
of 57